Daniel J. Lippis Edwards Lifesciences Corp (EW) insider trading activity

Daniel J. Lippis is CVP, JAPAC of Edwards Lifesciences Corp. Currently has a direct ownership of 26,345 shares of EW, which is worth approximately $2.06 Million. The most recent transaction as insider was on May 11, 2025, when has been sold 271 shares (Common Stock) at a price of $73.68 per share, resulting in proceeds of $19,967. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26.3K

16.63% 3M change

12.05% 12M change

Total Value Held $2.06 Million

Daniel J. Lippis Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 11 2025	SELL Payment of exercise price or tax liability	$19,967 $73.68 p/Share	271 Reduced 1.02%	26,345 Common Stock
May 09 2025	SELL Open market or private sale	$24,558 $74.42 p/Share	330 Reduced 1.22%	26,616 Common Stock
May 09 2025	BUY Exercise of conversion of derivative security	$14,942 $45.28 p/Share	330 Added 1.21%	26,946 Common Stock
May 08 2025	BUY Grant, award, or other acquisition	-	4,225 Added 13.7%	26,616 Common Stock
May 04 2025	SELL Payment of exercise price or tax liability	$18,685 $75.65 p/Share	247 Reduced 1.09%	22,391 Common Stock
May 03 2025	SELL Payment of exercise price or tax liability	$17,021 $75.65 p/Share	225 Reduced 0.98%	22,638 Common Stock
Apr 08 2025	SELL Open market or private sale	$21,183 $70.61 p/Share	300 Reduced 1.3%	22,863 Common Stock
Apr 08 2025	BUY Exercise of conversion of derivative security	$13,584 $45.28 p/Share	300 Added 1.28%	23,163 Common Stock
Mar 10 2025	SELL Open market or private sale	$27,792 $69.48 p/Share	400 Reduced 1.74%	22,588 Common Stock
Mar 10 2025	BUY Exercise of conversion of derivative security	$18,112 $45.28 p/Share	400 Added 1.71%	22,988 Common Stock
Feb 18 2025	SELL Payment of exercise price or tax liability	$16,914 $76.19 p/Share	222 Reduced 0.97%	22,588 Common Stock
Feb 17 2025	SELL Payment of exercise price or tax liability	$12,571 $76.19 p/Share	165 Reduced 0.72%	22,810 Common Stock
Feb 16 2025	SELL Payment of exercise price or tax liability	$16,304 $76.19 p/Share	214 Reduced 0.92%	22,975 Common Stock
Feb 13 2025	SELL Open market or private sale	$38,170 $76.34 p/Share	500 Reduced 2.11%	23,189 Common Stock
Feb 13 2025	BUY Exercise of conversion of derivative security	$22,640 $45.28 p/Share	500 Added 2.07%	23,689 Common Stock
Jan 16 2025	SELL Open market or private sale	$34,380 $68.76 p/Share	500 Reduced 2.11%	23,189 Common Stock
Jan 16 2025	BUY Exercise of conversion of derivative security	$22,640 $45.28 p/Share	500 Added 2.07%	23,689 Common Stock
Dec 16 2024	SELL Open market or private sale	$185,200 $74.08 p/Share	2,500 Reduced 9.73%	23,189 Common Stock
Dec 16 2024	BUY Exercise of conversion of derivative security	$113,200 $45.28 p/Share	2,500 Added 8.87%	25,689 Common Stock
Jul 11 2024	SELL Open market or private sale	$47,090 $94.18 p/Share	500 Reduced 2.11%	23,189 Common Stock
Jul 11 2024	BUY Exercise of conversion of derivative security	$22,640 $45.28 p/Share	500 Added 2.07%	23,689 Common Stock
Jul 07 2024	SELL Payment of exercise price or tax liability	$37,851 $92.32 p/Share	410 Reduced 1.74%	23,189 Common Stock
Jun 20 2024	SELL Open market or private sale	$48,150 $90.0 p/Share	535 Reduced 2.22%	23,512 Common Stock
Jun 20 2024	BUY Exercise of conversion of derivative security	$24,224 $45.28 p/Share	535 Added 2.18%	24,047 Common Stock
May 11 2024	SELL Payment of exercise price or tax liability	$32,693 $86.72 p/Share	377 Reduced 1.58%	23,512 Common Stock

DJL

Daniel J. Lippis

CVP, JAPAC

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EW shares.

Notify only if

Value

Insider Trading

Get notified when an Edwards Lifesciences Corp insider buys or sells EW shares.

Notify only if

Operation

Value

Type

News

Receive news related to Edwards Lifesciences Corp

Track Activities on EW

Account